61![PREFERRED STEP THERAPY POLICY Insulin (Rapid-Acting) Preferred Step Therapy Program To Initiate a Coverage Review, Call[removed]DRUGS AFFECTED: Apidra® (insulin glulisine [rDNA origin] injection – Sanofi Aventi PREFERRED STEP THERAPY POLICY Insulin (Rapid-Acting) Preferred Step Therapy Program To Initiate a Coverage Review, Call[removed]DRUGS AFFECTED: Apidra® (insulin glulisine [rDNA origin] injection – Sanofi Aventi](https://www.pdfsearch.io/img/d7627c6b794ef89465fa3098ec41fa3d.jpg) | Add to Reading ListSource URL: statehealthplan.state.nc.usLanguage: English - Date: 2014-05-05 10:56:54
|
---|
62![Correct Quantities for NB Drug Plans Claim Submissions The tables below list correct quantities for various categories of medications and for a number of specific medications. If you are unsure of the correct unit of mea Correct Quantities for NB Drug Plans Claim Submissions The tables below list correct quantities for various categories of medications and for a number of specific medications. If you are unsure of the correct unit of mea](https://www.pdfsearch.io/img/6cfa8c24d920d9176a0f3efc400510d4.jpg) | Add to Reading ListSource URL: www.gnb.caLanguage: English - Date: 2014-06-24 09:33:12
|
---|
63![PREFERRED STEP THERAPY POLICY Insulin (Short- and Intermediate-Acting) Preferred Step Therapy Program To Initiate a Coverage Review, Call[removed]DRUGS AFFECTED: Humulin® R (Regular insulin human injection, USP [ PREFERRED STEP THERAPY POLICY Insulin (Short- and Intermediate-Acting) Preferred Step Therapy Program To Initiate a Coverage Review, Call[removed]DRUGS AFFECTED: Humulin® R (Regular insulin human injection, USP [](https://www.pdfsearch.io/img/1c4daf3f7d392b49b4154a2b415ee4f4.jpg) | Add to Reading ListSource URL: statehealthplan.state.nc.usLanguage: English - Date: 2014-05-05 10:56:55
|
---|
64![■ Medical Safety Information Pharmaceuticals and Medical Devices Agency http://www.pmda.go.jp/english/service/medical_info.html No. 37 April, 2013 ■ Medical Safety Information Pharmaceuticals and Medical Devices Agency http://www.pmda.go.jp/english/service/medical_info.html No. 37 April, 2013](https://www.pdfsearch.io/img/cbc66721356185d2181f438fab5e58f2.jpg) | Add to Reading ListSource URL: www.pmda.go.jpLanguage: English - Date: 2014-02-19 00:54:13
|
---|
65![Kansas Medical Assistance Program P O Box 3571 Topeka, KS[removed]Provider[removed]Beneficiary[removed] Kansas Medical Assistance Program P O Box 3571 Topeka, KS[removed]Provider[removed]Beneficiary[removed]](https://www.pdfsearch.io/img/f6e071b8fc2507c738735e1cb00ab9f4.jpg) | Add to Reading ListSource URL: www.kdheks.govLanguage: English - Date: 2013-07-31 16:02:31
|
---|
66![C O M M O N LY U S E D A N T I - H Y P E R G LYC E M I C A G E N T S The following charts include commonly used medications for diabetes. For information on dosing and other considerations, please refer to pharmaceutical C O M M O N LY U S E D A N T I - H Y P E R G LYC E M I C A G E N T S The following charts include commonly used medications for diabetes. For information on dosing and other considerations, please refer to pharmaceutical](https://www.pdfsearch.io/img/0c4a2abc038b40c9c8fcfd434f301117.jpg) | Add to Reading ListSource URL: www.mass.govLanguage: English - Date: 2013-08-30 20:21:00
|
---|
67![These highlights do not include all the information needed to use NovoLog safely and effectively. See full prescribing information for NovoLog.NovoLog® (insulin aspart [rDNA origin] injection) solution for subcutaneous These highlights do not include all the information needed to use NovoLog safely and effectively. See full prescribing information for NovoLog.NovoLog® (insulin aspart [rDNA origin] injection) solution for subcutaneous](https://www.pdfsearch.io/img/0c39d67bc43ae925afbf21526f7877d9.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
68![This consult is in response to CBER’s August 27, 2002, e-mail requesting assistance on providing data on the use of the product Neumega (oprelvelin) This consult is in response to CBER’s August 27, 2002, e-mail requesting assistance on providing data on the use of the product Neumega (oprelvelin)](https://www.pdfsearch.io/img/04753257b20365fa52df67e1fc6834cc.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2006-11-13 08:05:34
|
---|
69![Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology](https://www.pdfsearch.io/img/221b79a0cb8b4b18e3182e1b74a23243.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
70![CLINICAL REVIEW Application Type Submission Number Submission Code Letter Date CLINICAL REVIEW Application Type Submission Number Submission Code Letter Date](https://www.pdfsearch.io/img/b7152ef7c317d403dfd1ced542cbcb59.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|